Accutane iPLEDGE Glitches Warrant Start Up Delay, Dermatology Group Urges

Implementation of the iPLEDGE pregnancy risk management program for Roche's acne therapy Accutane and isotretinoin generics should be postponed until May 1, the American Academy of Dermatology said